Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Settings
Language
ENGLISH
Currency
USD
Theme
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rank in Stocks #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Share Price
$4.84
Market Cap
$633.18M
Change (1 day)
3.20%
Change (1 year)
0.00%
Country
GB
Trade Exscientia plc (EXAI)

Category

Healthcare
P/B ratio for Exscientia plc (EXAI)
P/B ratio as of April 2026 TTM: 1.26
According to Exscientia plc latest financial reports and stock price the company's current price-to-book ratio (TTM) is 1.26. At the end of 2022 the company had a P/B ratio of 1.36.
P/B ratio history for Exscientia plc from 2019 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 1.26 -27.40%
2023 1.74 28.33%
2022 1.36 -67.63%
2021 4.20 -85.97%
2020 29.94 -64.81%
2019 85.08 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.2875 318.55%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.074 380.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.5436 101.35%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5196 257.76%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5468 101.60%
AU